Hollywood Mark
SEC insider (Form 3/4/5 filer). CIK 0002104446. EVP & Chief Operating Officer at Zymeworks Inc. (ZYME). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in MIDDLETOWN, DE.
Companies Hollywood Mark has filed insider reports for
- Zymeworks Inc. (ZYME): Officer, EVP & Chief Operating Officer
Hollywood Mark
CIK: 0002104446
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (16.7%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZYME
Zymeworks Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 6, 2026ZYME
Zymeworks Inc.
AwardDirect939 shares at avg. $22.22$21K - Jan 12, 2026ZYME
Zymeworks Inc.
ExerciseDirect17.7K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
SaleDirect6.1K shares at avg. $22.67$139K - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
70K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
47K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectPerformance Stock Unit
66K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 | ZYME Zymeworks Inc. | Award | 939 | $22.22 | $20,865 | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Exercise | 17,666 | - | $0 | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Sale | 6,120 | $22.67 | $138,762 | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 47,000 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Performance Stock Unit | 66,000 | - | - | Direct |
1-6 of 6 transactions